Previous Close | 29.66 |
1-Year Change | -12.64% |
6-Months Change | -15.88% |
3-Months Change | 1.51% |
Moving Avg (50d) | 30.99 |
Moving Avg (200d) | 33.801 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 0.981B |
Beta (3-Years) | 0.65 |
Revenue Growth (ttm) | 51.14% |
Net Profit Margin (ttm) | 1.65% |
Return On Assets (ttm) | 0.77% |
EPS (ttm) | 0.15 |
PE Ratio (ttm) | 197.73 |
Dividend Yield | % |
Asset Description: | Collegium Pharmaceutical, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2025-01-27 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
29.067 | 28.177 | 27.584 | 26.694 | 25.211 | 23.728 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Pharmaceuticals |
Country: | United States |